Korean Society of Toxicology /Environmental Mutagens and Carcinogens
Date
May 23, 2008
Place
Seoul National University, Hoam Convention Center
Predictive Toxicology & Drug Discovery
Session I. Predictive Toxicology & Bioinformatics
Part I.
Toxicology in 21st Century: Paradigm Shift to Systems and Predictive Toxicology and OECD/IPCS(WHO) Roles
Sue Nie Park, PhD (NITR/KFDA, Korea)
Bioinformatics for Predictive Toxicogenomics
Ju Han Kim, MD, PhD (Seoul National University, Korea)
Part II.
Understanding and Implication of Meta-analysis
Chun-Bae Kim, MD, PhD (Yonsei University, Korea)
The Role of Metabonomics in Exploring Drug Toxicity and Diseases
Yulan Wang, PhD (Wuhan Institute of Physics and Mathematics, China)
Computational Modeling Approaches toward System Biology: in vivo (hydrazine and ANIT) & in vitro (amino acids) studies
Jung-Wook Bang, PhD (Imperial College London, UK)
Session II. 7th KIT Symposium: Frontier Drug Discovery
Part I: Frontier Research for Drug Discovery
An Array of FDA Efforts in Toxicogenomics Weida Tong, PhD (NCTR/FDA, USA)
DWP418, A Novel Cancer Gene Therapeutic with an Emerging Role in Tumor Tissue Penetration
Chae-Ok Yun, PhD (Yonsei University, Korea)
Part II: Case Review, Success Stories in Drug Development
Developmental Strategy of Udenafil, a Novel PDE5 Inhibitor
Byoung Ok Ahn, DVM, PhD (Dong-A Pharmaceutical Co. Ltd, Korea)
Development and Licensing of Ilaprazole
Lee Jun Yeoun. (Il Yang Pharmaceutical Co., Korea)
